相似文献
1
Genes in inflammatory bowel disease: lessons from complex diseases.
Clin Med (Lond). 2011 Feb;11(1):8-10. doi: 10.7861/clinmedicine.11-1-8.
2
New genes in inflammatory bowel disease: lessons for complex diseases?
Lancet. 2006 Apr 15;367(9518):1271-84. doi: 10.1016/S0140-6736(06)68345-1.
3
Genetics of inflammatory bowel disease: population aspects.
Gastroenterology. 2008 Jun;134(7):2190-1. doi: 10.1053/j.gastro.2008.01.087. Epub 2008 May 15.
4
Genetics of inflammatory bowel disease: progress and prospects.
Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R161-8. doi: 10.1093/hmg/ddh079. Epub 2004 Feb 5.
5
Inflammatory bowel disease. I. Genetic epidemiology.
Mol Genet Metab. 2001 Sep-Oct;74(1-2):1-21. doi: 10.1006/mgme.2001.3199.
6
What do the terms "genetic predisposition" and "genetic heterogeneity" mean in relation to inflammatory bowel disease?
Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S31-2. doi: 10.1002/ibd.20563.
7
Genetics of inflammatory bowel diseases--past, present, and future.
Dig Dis. 2003;21(2):85-90. doi: 10.1159/000073241.
8
Early onset IBD: what's the difference?
Dig Liver Dis. 2008 Jan;40(1):12-5. doi: 10.1016/j.dld.2007.07.166. Epub 2007 Nov 7.
9
How do genetics help an understanding of IBD epidemiology?
Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S29-30. doi: 10.1002/ibd.20690.
10
Inflammatory bowel disease--environmental modification and genetic determinants.
Pediatr Clin North Am. 2006 Aug;53(4):727-49. doi: 10.1016/j.pcl.2006.05.009.
引用本文的文献
1
Prognostic Factors of Biologic Therapy in Pediatric IBD.
Children (Basel). 2022 Oct 14;9(10):1558. doi: 10.3390/children9101558.
2
The fungal microbiota of de-novo paediatric inflammatory bowel disease.
Microbes Infect. 2015 Apr;17(4):304-10. doi: 10.1016/j.micinf.2014.12.001. Epub 2014 Dec 15.
3
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?
World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):550-9. doi: 10.4291/wjgp.v5.i4.550.
本文引用的文献
1
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
Nat Genet. 2010 Dec;42(12):1118-25. doi: 10.1038/ng.717.
2
Genetics of childhood-onset inflammatory bowel disease.
Inflamm Bowel Dis. 2011 Jan;17(1):346-61. doi: 10.1002/ibd.21283.
3
The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival.
J Immunol. 2010 Jun 15;184(12):7247-56. doi: 10.4049/jimmunol.0901479. Epub 2010 May 7.
4
The intestinal microbiota in inflammatory bowel diseases: time to connect with the host.
Curr Opin Gastroenterol. 2010 Jul;26(4):327-31. doi: 10.1097/MOG.0b013e328339536b.
5
Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
Am J Gastroenterol. 2010 Aug;105(8):1811-9. doi: 10.1038/ajg.2010.95. Epub 2010 Mar 2.
6
Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.
Inflamm Bowel Dis. 2010 Jul;16(7):1108-17. doi: 10.1002/ibd.21176.
7
NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation.
Nat Med. 2010 Jan;16(1):90-7. doi: 10.1038/nm.2069. Epub 2009 Dec 6.
8
Natural history and complications of IBD.
Curr Gastroenterol Rep. 2009 Dec;11(6):481-7. doi: 10.1007/s11894-009-0073-8.
9
Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry.
Nat Immunol. 2010 Jan;11(1):55-62. doi: 10.1038/ni.1823. Epub 2009 Nov 8.
10
Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history.
Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):513-34. doi: 10.1586/egh.09.45.
Zotero 插件